Article first published online: 15 FEB 2013
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 58, Issue 1, pages 139–149, July 2013
How to Cite
Fu, J., Zhang, Z., Zhou, L., Qi, Z., Xing, S., Lv, J., Shi, J., Fu, B., Liu, Z., Zhang, J.-Y., Jin, L., Zhao, Y., Lau, G. K.K., Zhao, J. and Wang, F.-S. (2013), Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma. Hepatology, 58: 139–149. doi: 10.1002/hep.26054
Potential conflict of interest: Nothing to report.
Supported in part by grants from the National Natural Science Foundation of China (30901328), the National Key Basic Research Program of China (2009CB522500, 2012CB519005), and the National Grand Program on Key Infectious Disease (2012ZX10002-007-002).
- Issue published online: 24 JUN 2013
- Article first published online: 15 FEB 2013
- Accepted manuscript online: 7 SEP 2012 09:03AM EST
- Manuscript Accepted: 24 AUG 2012
- Manuscript Received: 11 DEC 2011
Additional Supporting Information may be found in the online version of this article.
|HEP_26054_sm_SuppFig1.tif||2013K||Supporting Information Figure 1.|
|HEP_26054_sm_SuppFig2.tif||4083K||Supporting Information Figure 2.|
|HEP_26054_sm_SuppFig3.tif||8498K||Supporting Information Figure 3.|
|HEP_26054_sm_SuppFig4.tif||10892K||Supporting Information Figure 4.|
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.